PeptiDream Inc. PPTDF
6.80 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
6.80 Day range 6.80
5.88 52-week range 12.85
- YTD
- -45.51%
- 1 year
- -38.74%
- Market cap
- 874.26M
- EPS (ttm)
- -0.18
- YTD return
- -45.51%
- 1-year return
- -38.74%
- Volume
- 250
- Avg volume
- 457
- Open
- 6.80
- Previous close
- 6.80
- Day's range
- 6.80 – 6.80
- 52-week range
- 5.88 – 12.85
2Y -10.20 (-60.00%)
News
PeptiDream (PPTDF) Expected to Announce Quarterly Earnings on Wednesday 
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer 
PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan 
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan 
PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner 
PeptiDream Inc. (PPTDF) Q4 2025 Earnings Call Transcript 
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan 
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
Your note
Sign in to keep a note on PPTDF — it syncs with the Stock Master app.